V-MANTINE 10 MG

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Osta se nyt

Aktiivinen ainesosa:

MEMANTINE HYDROCHLORIDE

Saatavilla:

VITAMED PHARMACEUTICAL INDUSTRIES LTD

ATC-koodi:

N06DX01

Lääkemuoto:

TABLETS ORODISPERSIBLE

Koostumus:

MEMANTINE HYDROCHLORIDE 10 MG

Antoreitti:

PER OS

Prescription tyyppi:

Required

Valmistaja:

GENEPHARM S.A., GREECE

Terapeuttinen alue:

MEMANTINE

Käyttöaiheet:

Treatment of patients with moderate to severe Alzheimer's disease.

Valtuutus päivämäärä:

2019-04-10

Pakkausseloste

                                1
Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) - 1986
This medicine is dispensed with a doctor’s prescription only
V-Mantine 10 mg
V-Mantine 20 mg
Orodispersible tablets
Active ingredient:
Each orodispersible tablet of V-Mantine 10 mg contains 10 mg Memantine
Hydrochloride
Each orodispersible tablet of V-Mantine 20 mg contains 20 mg Memantine
Hydrochloride
Inactive ingredients and allergens in the medicine- see section 6
"Additional information"
and in section 2 "Important information about some of the ingredients
of this medicine".
Read the entire leaflet carefully before you start using this
medicine. This leaflet
contains concise information about this medicine. If you have any
further questions,
consult your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It
may harm them, even if it seems to you that their illness is similar
to yours
1. What is this medicine intended for?
V-Mantine is intended for treatment of moderate to severe Alzheimer's
disease.
Therapeutic group: NMDA receptor antagonist.
V-Mantine belongs to a group of medicines known as anti-dementia
medicines. Memory
loss in Alzheimer’s disease is due to a disturbance in transmission
of nerve signals in the
brain. The brain contains so-called N-methyl-D-aspartate
(NMDA)-receptors. These
receptors are involved in transmitting nerve signals that are
important in learning and
memory. V-Mantine acts on NMDA-receptors, thus improving the
transmission of nerve
signals and the memory.
2. Before using this medicine
Do not use this medicine if:
•
You are sensitive (allergic) to the active ingredient or to any of the
other ingredients this
medicine contains (see section 6 "Additional information").
•
You are breastfeeding.
Special warnings about using this medicine
Before using V-Mantine, tell the doctor if:
•
You have a history of epilepsy (epileptic seizures).
•
You have recently experienced a myocardial infarction (heart attack),
or if you are
suffering
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste arabia 08-11-2023
Pakkausseloste Pakkausseloste heprea 08-11-2023

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia